| Aug 1 |
GeneDx Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Jul 31 |
GeneDx Holdings Corp. (WGS) Q2 2024 Earnings Call Transcript
|
| Jul 31 |
GeneDx Holdings Corp. 2024 Q2 - Results - Earnings Call Presentation
|
| Jul 30 |
GeneDx Holdings Corp. (WGS) Reports Q2 Loss, Tops Revenue Estimates
|
| Jul 30 |
GeneDx GAAP EPS of -$1.10 misses by $0.46, revenue of $70.51M beats by $11.2M
|
| Jul 30 |
GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients
|
| Jul 30 |
GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights
|
| Jul 29 |
GeneDx Q2 2024 Earnings Preview
|
| Jul 23 |
Best Momentum Stocks to Buy for July 23rd
|
| Jul 23 |
GeneDx Holdings Corp.'s (NASDAQ:WGS) institutional investors lost 5.7% over the past week but have profited from longer-term gains
|
